Tanaka, Eiji

Highly Purified Eicosapentaenoic Acid Treatment Improves Nonalcoholic Steatohepatitis

Tanaka, N., Sano, K., Horiuchi, A., Tanaka, E., Kiyosawa, K., & Aoyama, T. (2008) · Journal of Clinical Gastroenterology

Liver Disease Diagnosis and TreatmentFatty Acid Research and Health

Cited by 248

Serum wisteria floribunda agglutinin-positive Mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosis

Umemura, T., Joshita, S., Sekiguchi, T., Usami, Y., Shibata, S., Kimura, T., Komatsu, M., Matsumoto, A., Ota, M., & Tanaka, E. (2015) · American Journal of Gastroenterology

Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment

Cited by 127

Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice

Tanaka, N., Zhang, X., Sugiyama, E., Kono, H., Horiuchi, A., Nakajima, T., Kanbe, H., Tanaka, E., Gonzalez, F. J., & Aoyama, T. (2010) · Biochemical Pharmacology

Fatty Acid Research and HealthLiver Disease Diagnosis and Treatment

Cited by 78

Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis

Joshita, S., Umemura, T., Yamashita, Y., Sugiura, A., Yamazaki, T., Fujimori, N., Matsumoto, A., & Tanaka, E. (2019) · Hepatology Research

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 38

Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis

Sekiguchi, T., Umemura, T., Fujimori, N., Shibata, S., Ichikawa, Y., Kimura, T., Joshita, S., Komatsu, M., Matsumoto, A., Tanaka, E., et al. (2015) · PLOS ONE

Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment

Cited by 27